Clinical Trials Browser

Phase 1 × NIH × iadademstat × Clear all

NCT06514261 2026-03-19

Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute